Colorectal Cancer
Entity.
- Evidence
- 2,119 documents · 430 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 11 Mar 2026, last seen 8 Nov 2026
- Measured
- 6% of mentions say something specific about it; the rest only name it
- As of
- 9 Nov 2026
Where this comes from
- OncoDaily · 2026-11-08 · Agenus Reports Long-Term Survival Outcomes of BOT+BAL in Refractory MSS Colorectal Cancer at SITC 2026 (opens the source in a new tab)
- Cell Signal · 2026-11-07 · Rigosertib promotes ferroptosis in colorectal cancer by increasing Keap1, reducing Nrf2/SLC7A11 signaling, and facilitating autophagic GPX4 degradation. (opens the source in a new tab)
- European Medical Journal · 2026-11-07 · Rectal Cancer Watch-and-Wait Strategy Gains Wider Adoption (opens the source in a new tab)
- J Gastrointest Cancer · 2026-11-07 · Incidence of Colorectal Cancer After Endoscopic Mucosal Resection: A Multicenter Electronic Health Record Cohort Study. (opens the source in a new tab)
- J Prim Care Community Health · 2026-11-07 · Health Literacy and Colorectal Cancer Screening: A Community-Based Programme. (opens the source in a new tab)
- Support Care Cancer · 2026-11-07 · Digital health support for colorectal cancer patients: a patient centred approach. (opens the source in a new tab)
- Parasites Hosts Dis · 2026-11-06 · Toxoplasma gondii GRA16-induced apoptosis in KRAS-mutant colorectal cancer cells is linked to coordinated p53 and PP2A-B55 signaling. (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-11-06 · Targeting REV1 Exposes Context-Dependent Therapeutic Responses in Colorectal Cancer (opens the source in a new tab)
- Cancer Causes Control · 2026-11-06 · Proxy-mediated bias in non-invasive colorectal cancer risk predictors: an evidence appraisal for multiethnic Southeast Asian population. (opens the source in a new tab)
- Int J Oncol · 2026-11-06 · PLD2 fuels 5‑fluorouracil resistance in colorectal cancer: Hypoxic hijacking of autophagy unveils a novel therapeutic vulnerability. (opens the source in a new tab)
What is claimed about it
- Reported by two: Reported by two sources that did not copy each other.
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- Sotorasib plus panitumumab extends progression-free survival in KRAS G12C-mutant colorectal cancer Could not check · first reported 7 Nov 2026
- Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026 - BioSpace Single source · first reported 6 Nov 2026
- Comparative efficacy and safety of second- and later-line BRAF-targeted regimens in BRAF V600E-mutant metastatic colorectal cancer: A systematic review and network meta-analysis. Could not check · first reported 6 Nov 2026
- A tumor transcriptomic atlas across eight decades of life reveals distinct features of early-onset colorectal cancer. Reported by two · first reported 4 Nov 2026
- IFNAR1 stabilization sustains CD8+ T cell persistence in IFN-high colorectal cancer liver metastases Could not check · first reported 4 Nov 2026
- The role of gut microbiota on the tumor microenvironment in colorectal cancer: a systematic review and meta-analysis. Single source · first reported 4 Nov 2026
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer Could not check · first reported 3 Nov 2026
- Therapy-induced tumour senescence drives oxaliplatin resistance via ADORA1-dependent palmitic acid metabolic reprogramming in colorectal cancer. Could not check · first reported 3 Nov 2026